3P Biopharmaceuticals awards the prize for the best Master’s Thesis (TFM)

At the closing of the fifth edition of the Master in Galenic Design and Manufacturing in the Pharmaceutical Industry of the University of Navarra.

3P Biopharmaceuticals (3P), a leading organization specializing in the development of cGMP processes and manufacturing of biological products (CDMO), has awarded the prize for the best Master’s Final Project (TFM) of the fifth edition of the Master’s Degree in Galenic Design and Manufacturing in the Pharmaceutical Industry.

The award was presented by the CEO of 3P Biopharmaceuticals, Dámaso Molero, during the academic closing ceremony of the master’s degree. The award is part of the agreement signed in 2021 between 3P and the Faculty of Pharmacy of the University of Navarra, which aims to promote training and research in technology and production of new medicines, especially biotechnological ones.

The areas of interest of this agreement include R&D therapies, biological drug development, gene and cell therapy development and manufacturing technologies, among others. The agreement reached between the university and 3P is a very important recognition of the teaching work, both theoretical and practical, that is being carried out by the Faculty of Pharmacy and Nutrition.

3P Biopharmaceuticals awards the prize for the best Master's Thesis (TFM)

This academic event was attended by prestigious profiles of the University of Navarra such as Ms. Maribel Calvo (Director of the Master) and Mr. Juan Manuel Irache (Vice-Dean of Postgraduate Studies), who made the presentation of the event and the guests, as well as the closing of the event.

The experimental work awarded under the title: “Implementation of a Quality Assurance System for the manufacture of famotidine 40mg floating tablets” has been carried out by Claudia Barranco del Pino. The winner was chosen by an evaluation commission composed of 3 members of 3P and will receive a prize of 400 euros.
Dámaso Molero, expressed his pleasure at awarding this prize: “Each and every one of them has carried out work of a high scientific and technical level and quality that will undoubtedly be of great help to the national and international pharmaceutical and biotechnological sector”.

In addition to the 3P Master’s Thesis Award, the collaboration between the two entities includes scholarships and prizes for the most outstanding students, as well as activities, courses, seminars, and scientific meetings.

Our dedicated team of specialists will be happy to discuss any of your CDMO supply chain needs. Contact us on +34 948 346 480 or email withinus@3pbio.com

Related Content

BrainEver and 3P Biopharmaceuticals collaborate on development of recombinant human homeoprotein Engrailed-1

Published: 15th November 2022
3P Bio will focus on the transfer of the production process as well as the cGMP manufacturing of the drug substance to be used in Phase I and II clinical trials. The novel drug could cure neurodegenerative diseases such as Amyotrophic Lateral Sclerosis.
Read more

3P Biopharmaceuticals among the 100 best companies to work for in Spain

Published: 27th September 2022
The prestigious ranking is based on an exhaustive questionnaire that Actualidad Económica prepares and publishes every year, and which seeks to evaluate and reward those companies whose human resources management makes them benchmarks.
Read more

3P Biopharmaceuticals appoints Kenneth McMahon as Head of Quality Control

Published: 13th September 2022
Kenneth McMahon has a PhD in molecular microbiology and a solid experience of over 10 years in both Quality Assurance (QA) and Quality Control (QC) departments.
Read more

Get in touch

Let’s discuss your biologics journey.

Discover more about our people, our passion, and how we can work together to improve lives.